A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of wAIHA

Clinical trial NCT03764618 · COMPLETED

Trial details

NCT number: NCT03764618
Sponsor: Rigel Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Warm Antibody Autoimmune Hemolytic Anemia

Start date: 2019-04-24
Primary completion: 2022-04-11
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.